| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.28▼ | 2.27▼ | 2.27▼ | 2.24▲ | 1.89▲ |
| MA10 | 2.28▼ | 2.27▼ | 2.31▼ | 2.05▲ | 2.14▲ |
| MA20 | 2.28▼ | 2.30▼ | 2.30▼ | 1.92▲ | 2.55▼ |
| MA50 | 2.28▼ | 2.27▼ | 2.12▲ | 2.22▲ | 2.63▼ |
| MA100 | 2.30▼ | 2.10▲ | 1.98▲ | 2.67▼ | 4.18▼ |
| MA200 | 2.29▼ | 1.97▲ | 1.98▲ | 2.66▼ | 8.19▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▼ | -0.008▼ | -0.019▼ | 0.082▲ | -0.062▼ |
| RSI | 42.273▼ | 46.181▼ | 52.387▲ | 57.138▲ | 46.947▼ |
| STOCH | 43.981 | 22.918 | 14.179▼ | 87.777▲ | 24.478 |
| WILL %R | -100.000▼ | -100.000▼ | -75.610▼ | -22.628▲ | -51.813 |
| CCI | -94.915 | -58.333 | -59.497 | 121.540▲ | -15.951 |
|
Thursday, May 07, 2026 07:04 AM
Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such ...
|
|
Sunday, April 26, 2026 01:24 PM
Following the successful spin-off of its Sandoz generics division in late 2023, Novartis AG (NYSE:NVS) has transformed into a high-margin, pure-play innovative medicines company that is currently ...
|
|
Friday, April 24, 2026 05:46 AM
Novartis (NYSE:NVS) said the European Medicines Agency’s Committee for Medicinal Products for Human Use has issued a favourable opinion recommending approval of Itvisma, an intrathecal gene therapy ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 07/05/26 | 2.35 | 2.35 | 2.26 | 2.26 | 875,357 |
| 06/05/26 | 2.30 | 2.415 | 2.20 | 2.40 | 725,476 |
| 05/05/26 | 2.29 | 2.38 | 2.19 | 2.27 | 1,737,487 |
| 04/05/26 | 2.00 | 2.35 | 1.98 | 2.28 | 1,976,460 |
| 01/05/26 | 2.01 | 2.02 | 1.94 | 2.00 | 701,280 |
| 30/04/26 | 1.94 | 1.9999 | 1.86 | 1.97 | 1,098,120 |
| 29/04/26 | 1.90 | 1.90 | 1.79 | 1.84 | 653,023 |
| 28/04/26 | 1.89 | 2.005 | 1.85 | 1.85 | 1,330,004 |
| 27/04/26 | 1.78 | 1.935 | 1.75 | 1.89 | 1,022,138 |
| 24/04/26 | 1.73 | 1.82 | 1.73 | 1.74 | 856,181 |
|
|
||||
|
|
||||
|
|